论文部分内容阅读
目前对早期卵巢恶性肿瘤尚无简易可靠的诊断方法,较多卵巢癌在确诊时已属晚期,对预后影响很大。据报导原发性卵巢癌血清乳酸脱氢酶升高,可为诊断、疗效和是否复发的估计提供根据。为了观察血清乳酸脱氢酶在卵巢癌的诊断治疗中的应用价值,我们对26例卵巢癌(原发性23例,继发性3例)作了测定。此外还对13例原发性卵巢癌作了治疗前后的测定。同时为观察血清乳酸脱氢酶对卵巢癌的特异性程度,我们以其他妇科癌瘤40例和正常人作对照测定。实验方法及结果一、病例来源: 全部病例均为住院病人,皆经临床及病理
At present there is no simple and reliable diagnostic method for early ovarian cancer, more ovarian cancer is already in the late diagnosis, a great impact on prognosis. It is reported that elevated serum lactate dehydrogenase in primary ovarian cancer may provide a basis for the diagnosis, efficacy and whether the recurrence is estimated. In order to observe the value of serum lactate dehydrogenase in the diagnosis and treatment of ovarian cancer, we measured 26 cases of ovarian cancer (23 cases of primary and 3 cases of secondary). In addition, 13 cases of primary ovarian cancer before and after treatment was measured. At the same time to observe the specificity of serum lactate dehydrogenase on ovarian cancer, we have 40 cases of other gynecologic cancers and normal controls for the control. Experimental methods and results First, the source of the case: all cases were hospitalized patients, both through clinical and pathological